jRCTs041220085
Untitled Trial
Phase2 study of intrapatient dose escalation of biweekly trifluridine/tipiracil + bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (E BiTS study)
Japan Registry Clinical TrialRecruitment Completed
Study focus
- Disease/Condition
- colorectal cancer
- Study type
- Interventional
Sponsor & location
Timeline & enrollment
- Phase
- N/A
- Start date
- N/A
- End date
- N/A
ICD-10 classifications
Malignant neoplasm of colonMalignant neoplasm: Descending colonMalignant neoplasm: Colon, unspecifiedMalignant neoplasm: Ascending colonMalignant neoplasm: Overlapping lesion of colon
Data source
- Registry
- Japan Registry Clinical Trial
- Trial ID
- jRCTs041220085
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for jRCTs041220085 through Pure Global AI's free database. This phase not specified trial is sponsored by sponsor not specified and is currently Recruitment Completed. The study focuses on colorectal cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Japan Registry Clinical Trial data, helping medical device and pharmaceutical companies navigate clinical research efficiently.